Brown Brothers Harriman & Co’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.7K Hold
590
﹤0.01% 1207
2025
Q4
$24.3K Hold
590
﹤0.01% 1170
2025
Q3
$22K Hold
590
﹤0.01% 1147
2025
Q2
$21.5K Hold
590
﹤0.01% 1077
2025
Q1
$22.8K Hold
590
﹤0.01% 945
2024
Q4
$22.4K Hold
590
﹤0.01% 1003
2024
Q3
$24.7K Hold
590
﹤0.01% 909
2024
Q2
$24.1K Hold
590
﹤0.01% 865
2024
Q1
$24.4K Hold
590
﹤0.01% 861
2023
Q4
$23.9K Buy
+590
New +$22.5K ﹤0.01% 827

Other funds holding BME

Brown Brothers Harriman & Co's BME Position: Q1 2026 in Review

Brown Brothers Harriman & Co held its BlackRock Health Sciences Trust (BME) position steady in Q1 2026 at 590 shares worth $22.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1207.

Brown Brothers Harriman & Co first reported a position in BME in Q4 2023 and has held it in 10 quarters since. The position peaked at $24.7K in Q3 2024. 76 funds tracked by Wall St. Rank hold BME as of Q1 2026.

  • Brown Brothers Harriman & Co held 590 shares of BlackRock Health Sciences Trust worth $22.7K as of Q1 2026.
  • Brown Brothers Harriman & Co left its BlackRock Health Sciences Trust share count unchanged in Q1 2026.
  • BlackRock Health Sciences Trust made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q1 2026, its #1207 holding.
  • Brown Brothers Harriman & Co first reported a position in BlackRock Health Sciences Trust in Q4 2023 and has held it in 10 quarters since.
  • Brown Brothers Harriman & Co's BlackRock Health Sciences Trust position peaked at $24.7K in Q3 2024.
  • 76 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q1 2026, filed 14 May 2026.